Submissions

Medicines New Zealand has an important role to play in representing its members' views on Government policy, legislation and other matters open to public consultation.

2016

Submission on Draft Code for Therapeutic and Health Advertising and Draft Guidance Notes

Submission on MBIE Consultation Document: Trans-Pacific Partnership Agreement Amendment Bill: Patent Term Extensions 

Submission to Foreign Affairs, Defence and Trade Select Committee on the Trans-Pacific Partnership Agreement Amendment Bill 

Medicines New Zealand presented an oral submission to the Foreign Affairs, Defence and Trade Select Committee on the Trans-Pacific Partnership Agreement Amendment Bill on 11 August 2016.

Guideline on the Regulation of Therapeutic Products in New Zealand - Part 10: Requirements for information for prescribers and consumers (Edition 7.0)

Submission to Foreign Affairs, Defence and Trade Select Committee on the Trans-Pacific Partnership Agreement 

Medicines New Zealand also presented an oral submission to the Foreign Affairs, Defence and Trade Select Committee on the Trans-Pacific Partnership Agreement on 14 April 2016.

Submission on Consultation Document: Implementation of the Trans-Pacific Partnership Intellectual Property Chapter

2015

Response to Discussion Document Improving Access to Medicines and Devices in Primary Care

Submission on Update of the New Zealand Health Strategy Consultation Draft

Guideline on the Regulation of Therapeutic Products in New Zealand - Part 8: Pharmacovigilance (Edition 2.0)

New Zealand Medicines and Medical Devices Recall Code

Response to Pharmaceutical Margins

2014

PHARMAC Contestable Fund for Medicines for Rare Disorders Consultation and Draft RFP

Submission by Vaccines Member Companies of Medicines New Zealand to PHARMAC's Decision Criteria, Proposal for Change

Joint Submission on PHARMAC OPP Decision Criteria Chaired by Medicines New Zealand 

2013

Submission on the PHARMAC Consultation - Hospital Pharmaceuticals: Schedule Rules and Policy Changes

Submission on the Trans-Tasman Early Warning System of Safety Concerns with Medicines and Medical Devices

Medicines New Zealand Submission on a Possible Joint Regulatory Scheme Under ANZTPA

Comment on the Consultation Regulation Impact Statement - Regulating the Advertising of Therapeutic Goods to the General Public

Submission on International Harmonisation of Ingredient Names

Submission on the Feasibility of a New-to-Market Communication Scheme for Therapeutic Goods

2012

Medicines Amendment Bill

2010

Improving New Zealand's Environment to Support Innovation through Clinical Trials

Final Submission to the High Cost Medicines Panel

New Zealand Public Health and Disability Amendment Bill

Bridging the Gap - a Partnership Between Patients, Doctors and DHBs to Enhance Access to Unfunded Treatments

Consultation on the Proposed Pharmacist Prescriber Scope of Practice

2009

Patents Bill

New Appeals Process for Ethical Review Consultation Document

Initial Submission to the High Cost Medicines Panel

Proposed Clinical Trials Guidelines

Proposed Changes to Fees Payable Under the Medicines Regulations

Consumer Participation Discussion Panel

Proposal to Change the Format of Section H

2009/10 Multi-Product Tender

Input into Consultation on Revised Funding Application Guidelines

Input into the Consumer Advisory Committee Terms of Reference Review

Consultation on Proposal to Reinvest a Portion of Savings Back into Pharmacy Sector